GENEVA, Aug. 18 -- SUMITOMO PHARMA CO., LTD. (6-8, Doshomachi 2-chome, Chuo-ku, Osaka-shi, Osaka5410045), 住友ファーマ株式会社 (大阪府大阪市中央区道修町二丁目6番8号), NATIONAL CANCER CENTER (1-1, Tsukiji 5-chome, Chuo-ku, Tokyo1040045), 国立研究開発法人国立がん研究センター (東京都中央区築地五丁目1番1号) filed a patent application (PCT/JP2024/004222) for "TERTIARY AMIDE DE...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.